Bone Microstructure by Using HR-pQCT After Esophagectomy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age50-90
SponsorNagasaki University
About this trial
Esophagectomy is most curative treatment to esophageal cancer. However, osteoporosis , which is characterized by both the loss of bone mass and the deterioration of bone architecture, is a serious complication in the long course after surgery. The aim of the present study was to evaluate osteoporosis by using high-resolution peripheral quantitative computed tomography (HR-pQCT) in the long course after esophagectomy. At least 3 years should have elapsed since operation without recurrence of esophageal cancer.
Eligibility criteria
Qualifiers
At least 3 years have elapsed since esophagectomy due to esophageal cancer
Provide signed informed consent
Disqualifiers
Current use of the following osteoporosis agents; Teriparatide, Denosumab, and - -
bisphosphonate
Present malignancy (except in situ carcinoma)
Radiotherapy
Trial design
Treatments tested in this trial
- esophagectomy
Treatment groups
118 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov